Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Quest Diagnostics Inc.
DescriptionPolymerase chain reaction (PCR)-based serum assay for detecting mutations in fragile X mental retardation 1 (FMR1)
Molecular Target Fragile X mental retardation 1 (FMR1)
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationNeurology, Diagnostic
Indication DetailsDetect FMR1 mutations in potential carriers and newborns
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today